Simplex Trading’s CollPlant Biotechnologies CLGN Stock Holding History

Simplex Trading’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$63	Buy	+118	New	+$119	﹤0.01%	8892
2025 Q4	–	Sell	-90	Closed	–	–	8717
2025 Q3	$0	Sell	90 -3	-3%	-$7	﹤0.01%	9163
2025 Q2	$0	Buy	+93	New	+$193	﹤0.01%	8753
2023 Q4	–	Sell	-100	Closed	–	–	8886
2023 Q3	$0	Buy	+100	New	+$662	﹤0.01%	8769
2022 Q4	–	Sell	-585	Closed	-$3K	–	9315
2022 Q3	$3K	Buy	+585	New	+$4.75K	﹤0.01%	9052
2022 Q2	–	Sell	-825	Closed	-$7.58K	–	10058
2022 Q1	$9K	Sell	825 -781	-49%	-$8.59K	﹤0.01%	8943
2021 Q4	$26K	Buy	+1,606	New	+$28.7K	﹤0.01%	8070

Other funds holding CLGN

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LWMI

Legacy Wealth Management (Idaho) Boise, Idaho $201M AUM 259.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

WPC

Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return

Simplex Trading's CLGN Position: Q1 2026 in Review

Simplex Trading opened a new position in CollPlant Biotechnologies (CLGN) in Q1 2026: 118 shares worth $63. The stake represents ﹤0.01% of the portfolio and ranks #8892 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CLGN as recently as Q3 2025.

Simplex Trading first reported a position in CLGN in Q4 2021 and has held it in 7 quarters since. The position peaked at $26K in Q4 2021. 21 funds tracked by Wall St. Rank hold CLGN as of Q1 2026.

Simplex Trading held 118 shares of CollPlant Biotechnologies worth $63 as of Q1 2026.
CollPlant Biotechnologies was a new Simplex Trading position in Q1 2026.
CollPlant Biotechnologies made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8892 holding.
Simplex Trading first reported a position in CollPlant Biotechnologies in Q4 2021 and has held it in 7 quarters since.
Simplex Trading's CollPlant Biotechnologies position peaked at $26K in Q4 2021.
21 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.